【结 构 式】 |
【分子编号】41341 【品名】2-amino-6-bromopyridine; 6-bromo-2-pyridinamine; 6-bromo-2-pyridinylamine 【CA登记号】19798-81-3 |
【 分 子 式 】C5H5BrN2 【 分 子 量 】173.01218 【元素组成】C 34.71% H 2.91% Br 46.18% N 16.19% |
合成路线1
该中间体在本合成路线中的序号:(II)2-Amino-6-bromopyridine (II) was prepared by reaction of 2,6-dibromopyridine (I) with ammonium hydroxide in a pressure bomb at 170 C. The amino group of (III) was subsequently blocked as the pyrrole derivative (IV) by condensation with 2,5-hexanedione (III). Diazotization of p-aminophenyl ethanol (V) followed by treatment with KI gave iodo derivative (VI). Subsequent reaction of (VI) with SOCl2 provided chloride (VII). Arylpyridine (VIII) was obtained by lithiation of bromopyridine (IV) with BuLi, followed by conversion to the corresponding organozinc compound with ZnCl2 and palladium-catalyzed coupling with iodide (VII). Pyrrole ring cleavage in (VIII) upon treatment with hydroxylamine furnished aminopyridine (IX). Subsequent condensation with N-Boc-piperazine (X) provided adduct (XI). After acid cleavage of the Boc group of (XI), alkylation of the resulting piperazine with phenacyl chloride (XII) yielded the title compound. Alternatively, the title compound was obtained by condensation of chloride (IX) with N-phenacylpiperazine (XIII).
【1】 Qian, W.; Lowe, J.A.; Volkmann, R.A.; et al.; A new class of selective and potent inhibitors of neuronal nitric oxide synthase. Bioorg Med Chem Lett 1999, 9, 17, 2569. |
【2】 Lowe, J.A. III; Whittle, P.J. (Pfizer Inc.); 6-Phenylpyridyl-2-amine derivs.. EP 0891332; JP 1999510513; WO 9736871 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 10159 | 2,6-Dibromopyridine | 626-05-1 | C5H3Br2N | 详情 | 详情 |
(II) | 41341 | 2-amino-6-bromopyridine; 6-bromo-2-pyridinamine; 6-bromo-2-pyridinylamine | 19798-81-3 | C5H5BrN2 | 详情 | 详情 |
(III) | 24848 | acetonyl acetone;1,2-Diacetylethane;a,b-Diacetylethane;2,5-Diketohexane;Diacetonyl;Acetonylacetone;2,5-Dioxohexane;2,5-hexanedione | 110-13-4 | C6H10O2 | 详情 | 详情 |
(IV) | 41342 | 2-bromo-6-(2,5-dimethyl-1H-pyrrol-1-yl)pyridine | C11H11BrN2 | 详情 | 详情 | |
(V) | 14019 | p-Aminophenylethanol; 2-(4-Aminophenyl)-1-ethanol | 104-10-9 | C8H11NO | 详情 | 详情 |
(VI) | 30973 | 2-(4-iodophenyl)-1-ethanol | C8H9IO | 详情 | 详情 | |
(VII) | 41343 | 1-(2-chloroethyl)-4-iodobenzene | C8H8ClI | 详情 | 详情 | |
(VIII) | 41344 | 2-[4-(2-chloroethyl)phenyl]-6-(2,5-dimethyl-1H-pyrrol-1-yl)pyridine | C19H19ClN2 | 详情 | 详情 | |
(IX) | 41345 | 6-[4-(2-chloroethyl)phenyl]-2-pyridinamine; 6-[4-(2-chloroethyl)phenyl]-2-pyridinylamine | C13H13ClN2 | 详情 | 详情 | |
(X) | 13225 | N-tert-Butoxycarbonyl piperazine; tert-butyl 1-piperazinecarboxylate;tert-butyl piperazine-1-carboxylate | 143238-38-4 | C9H18N2O2 | 详情 | 详情 |
(XI) | 41346 | tert-butyl 4-[4-(6-amino-2-pyridinyl)phenethyl]-1-piperazinecarboxylate | C22H30N4O2 | 详情 | 详情 | |
(XII) | 38669 | 2-chloro-1-phenyl-1-ethanone | 532-27-4 | C8H7ClO | 详情 | 详情 |
(XIII) | 41347 | 1-phenyl-2-(1-piperazinyl)-1-ethanone | C12H16N2O | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(I)Condensation of 2-amino-6-bromopyridine (I) with ethoxycarbonyl isothiocyanate (II) in CH2Cl2 gives 1-(6-bromopyridin-2-yl)-3-(ethoxycarbonyl) thiourea (III), which by cyclization with hydroxylamine hydrochloride (IV) in the presence of DIEA in EtOH/MeOH yields 2-amino-5-bromo[1,2,4]triazolo[1,5-a]pyridine (V). N-Acylation of amine (V) with cyclopropanecarbonyl chloride (VI) using Et3N in acetonitrile, and subsequent treatment with methanolic ammonia, results in the carboxamide (VII) . Suzuki coupling of compound (VII) with 4-(hydroxymethyl)phenylboronic acid (VIII) in the presence of PdCl2(dppf) and K2CO3 in dioxane/H2O at 90 °C, followed by bromination with PBr3 in CHCl3, affords the benzyl bromide intermediate (IX), which is finally condensed with thiomorpholine-1,1-dioxide (X) using DIEA in CH2Cl2/MeOH .
Alternatively, condensation of (4-bromomethylphenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane (XI) with thiomorpholine 1,1-dioxide (X) by means of DIEA in CH2Cl2/MeOH gives intermediate (XII), which finally undergoes Suzuki coupling with aryl bromide (VII) in the presence of PdCl2(dppf) and K2CO3 in dioxane/H2O at 90 °C .
【1】 Menet, C.J.M., Smits, K.K. (Galapagos NV). 5-Phenyl-[1,2,4]triazolo[1,5-a]pyridine-2-yl carboxamides as JAK inhibitors. CN 102482273, EP 2445911, JP 2012530766, KR 2012107919, US 201331319, US 8088764, WO 2010149769. |
【2】 Menet, C.J.M., Smits, K.K. (Galapagos NV). Novel compound useful for the treatment of degenerative and inflammatory diseases. US 2012142678, US 8563545. |
【3】 Van ‘t Klooster, G.A.E., Brys, R.C.X., Van Rompaey, L.J.C., Namour, F.S. (Galapagos NV). Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical composition thereof. US 2013345209, WO 2013189771. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 41341 | 2-amino-6-bromopyridine; 6-bromo-2-pyridinamine; 6-bromo-2-pyridinylamine | 19798-81-3 | C5H5BrN2 | 详情 | 详情 |
(II) | 25964 | 1-[(isothiocyanatocarbonyl)oxy]ethane | 16182-04-0 | C4H5NO2S | 详情 | 详情 |
(III) | 67818 | 1-(6-bromopyridin-2-yl)-3-(ethoxycarbonyl)thiourea | C9H10BrN3O2S | 详情 | 详情 | |
(IV) | 65957 | Hydroxylamine hydrochloride; Hydroxylammonium chloride; Oxammonium hydrochloride | 5470-11-1 | H3NO.HCl | 详情 | 详情 |
(V) | 67819 | 2-amino-5-bromo[1,2,4]triazolo[1,5-a]pyridine | C6H5BrN4 | 详情 | 详情 | |
(VI) | 14061 | Cyclopropanecarbonyl chloride; Cyclopropanecarboxylic acid chloride | 4023-34-1 | C4H5ClO | 详情 | 详情 |
(VII) | 67820 | N-(5-bromo-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide | C10H9BrN4O | 详情 | 详情 | |
(VIII) | 67821 | 4-(hydroxymethyl)phenylboronic acid | 59016-93-2 | C7H9BO3 | 详情 | 详情 |
(IX) | 67822 | N-(5-(4-(bromomethyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide | C17H15BrN4O | 详情 | 详情 | |
(X) | 67823 | thiomorpholine-1,1-dioxide | 39093-93-1 | C4H9NO2S | 详情 | 详情 |
(XI) | 67824 | (4-bromomethylphenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane | 138500-85-3 | C13H18BBrO2 | 详情 | 详情 |
(XII) | 67825 | 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)thiomorpholine 1,1-dioxide | C17H26BNO4S | 详情 | 详情 |